| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/11/2002 | CA1341366C Molecular clones of the genome of htlv-iii |
| 06/08/2002 | CA2375097A1 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002045182A1 Multiplex winding helical structure and functional material |
| 06/06/2002 | WO2002044736A2 Diagnosis and treatment of epidermal or skin diseases |
| 06/06/2002 | WO2002044734A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | WO2002044733A2 Methods and compositions for sorting and/or determining microorganisms |
| 06/06/2002 | WO2002044724A1 Arrangement for the production testing and archiving of chemical or biological arrays bonded to a solid phase |
| 06/06/2002 | WO2002044722A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 06/06/2002 | WO2002044427A2 Cell based triple readout assay systems for identifying compounds that effect transcription |
| 06/06/2002 | WO2002044421A2 Reverse transcription reactions |
| 06/06/2002 | WO2002044420A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044419A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044417A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels |
| 06/06/2002 | WO2002044415A1 Method for screening of dna libraries and generation of recombinant dna constructs |
| 06/06/2002 | WO2002044413A2 Method of determining epidermal growth factor receptor and her2-neu gene expression and correlation of levels thereof with survival rates |
| 06/06/2002 | WO2002044409A2 Substrate linked directed evolution (slide) |
| 06/06/2002 | WO2002044407A2 Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion |
| 06/06/2002 | WO2002044406A2 Projection against mycobacterial infections |
| 06/06/2002 | WO2002044404A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism |
| 06/06/2002 | WO2002044400A2 Compositions and methods for extracting a nucleic acid |
| 06/06/2002 | WO2002044399A2 In vitro transcription method for rna amplification |
| 06/06/2002 | WO2002044396A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | WO2002044395A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | WO2002044394A2 Targetet retoviral vectors for cancer immunotherapy |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044392A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 06/06/2002 | WO2002044391A2 Methods and compositions for the introduction of molecules into cells |
| 06/06/2002 | WO2002044390A2 Floral development genes |
| 06/06/2002 | WO2002044389A1 Novel transcriptional factor enhancing the resistance of plants to osmotic stress |
| 06/06/2002 | WO2002044388A1 Production of heterologous polypeptides in yeast |
| 06/06/2002 | WO2002044386A2 Targeted regulation of gene expression |
| 06/06/2002 | WO2002044385A1 Gene encoding acetolactic acid synthase gene |
| 06/06/2002 | WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | WO2002044383A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 06/06/2002 | WO2002044382A1 Cytokine-like proteins |
| 06/06/2002 | WO2002044381A2 Human vno receptor (r1) |
| 06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044378A2 Wnt signalling assay, methods and uses thereof |
| 06/06/2002 | WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | WO2002044376A2 Modulation of gene expression using insulator binding proteins |
| 06/06/2002 | WO2002044375A2 Compositions and methods for diagnosing or treating psoriasis |
| 06/06/2002 | WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/06/2002 | WO2002044373A2 Adipocyte complement related protein zacrp12 |
| 06/06/2002 | WO2002044372A2 Nucleotide and protein sequence of helios 3 and methods of use |
| 06/06/2002 | WO2002044371A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | WO2002044369A1 Novel human chloride channel |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044367A1 Method of screening remedy for diabetes |
| 06/06/2002 | WO2002044366A2 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | WO2002044365A1 Mammalian nuclear receptor cofactor cf9 and methods of use |
| 06/06/2002 | WO2002044364A2 Polypeptides involved in immune response |
| 06/06/2002 | WO2002044362A1 Method of screening remedy for diabetes |
| 06/06/2002 | WO2002044361A2 Eukaryotic expression libraries based on double lox recombination and methods of use |
| 06/06/2002 | WO2002044360A2 Modified arginine deiminase |
| 06/06/2002 | WO2002044359A1 Enzyme with proteolytic activity |
| 06/06/2002 | WO2002044355A2 Protozoan expression systems for lysosomal storage disease genes |
| 06/06/2002 | WO2002044350A2 Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
| 06/06/2002 | WO2002044347A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044339A2 Nucleic acid amplification methods |
| 06/06/2002 | WO2002044337A2 Wooden leg gene, promoter and uses thereof |
| 06/06/2002 | WO2002044336A2 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | WO2002044335A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 06/06/2002 | WO2002044334A2 Recombinant rsv virus expression systems and vaccines |
| 06/06/2002 | WO2002044333A2 Polynucleotides useful for modulating transcription |
| 06/06/2002 | WO2002044329A2 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 06/06/2002 | WO2002044325A2 Antisense modulation of src-1 expression |
| 06/06/2002 | WO2002044323A2 Vectors for expressing heterologous peptides at the amino-terminus of potyvirus coat protein, methods for use thereof, plants infected with same and methods of vaccination using same |
| 06/06/2002 | WO2002044322A2 Bacteriophage composition useful in treating food products to prevent bacterial contamination |
| 06/06/2002 | WO2002044321A2 Rna interference mediating small rna molecules |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044213A1 New cytochrome p450 proteins and the corresponding dna sequences |
| 06/06/2002 | WO2002044211A2 Endozepine like protein, polynucleotide encoding them and methods of using the same |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044207A1 Immunotherapeutic methods and molecules |
| 06/06/2002 | WO2002044206A2 Membrane fusion proteins derived from reovirus |
| 06/06/2002 | WO2002044205A2 Peptides from ag85 of mycobacterium and uses thereof |
| 06/06/2002 | WO2002044203A2 Production of recombinant bmp-2 |
| 06/06/2002 | WO2002044202A2 Mutated immunogenic peptides derived from r9m, polynucleotides coding for same and therapeutic uses thereof |
| 06/06/2002 | WO2002044201A2 Haplotypes of the sah gene |
| 06/06/2002 | WO2002044199A2 Neurotoxins with enhanced target specificity |
| 06/06/2002 | WO2002044198A2 Haplotypes of the slc1a4 gene |
| 06/06/2002 | WO2002044197A2 Cytokine receptor binding peptides |
| 06/06/2002 | WO2002044195A2 Method for base sequencing and biologically active nucleic acids |
| 06/06/2002 | WO2002043864A2 Devices and methods for biochip multiplexing |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043757A2 Medicament for preventing or treating tumors caused by human papilloma virus type 18 |
| 06/06/2002 | WO2002043749A1 Inducing expression of heat shock proteins |
| 06/06/2002 | WO2002043741A2 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
| 06/06/2002 | WO2002043660A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | WO2002043658A2 Fcrn-based therapeutics for the treatment of auto-immune disorders |
| 06/06/2002 | WO2002043654A2 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 06/06/2002 | WO2002043650A2 Systems and methods for delivering interferon to a subject |